BridgeBio Pharma <BBIO.O>: BofA Global Research raises price objective to $104.00 from $101.00
BBIO•Related News
SolarMax Technology Announces Reverse Stock Split To Support Effort To Regain Compliance With Nasdaq’s Minimum Bid Price Requirement
SMXT•
Nvidia Launches Nemotron 3.5 Lightning Open 30B Mixture-Of-Experts Model
NVDA•
Bio-Key International Enters Into $2.5 Million Warrant Inducement Transaction
BKYI•
Shares of Gap Down About 4% After Barclays Downgrades to 'Equal-Weight'
GAP•
Sierra Bancorp releases investor deck outlining 10% annualized EPS growth strategy
BSRR•